Clinical trial

Efficacy and Safety of TELMINUVO to Stage 2 Hypertension

NCT01983735

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention TELMINUVO Tab. (80/2.5mg) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention TELMINUVO Tab. (80/5mg) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention S-amlodipine 2.5mg Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention S-amlodipine 5mg Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Efficacy and Safety of TELMINUVO to Stage 2 Hypertension

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2014-01-01

PhasePHASE3

Conditions

Hypertensionunresolved

Interventions

TELMINUVO Tab. (80/2.5mg)DRUG

TELMINUVO Tab. (80/5mg)DRUG

S-amlodipine 2.5mgDRUG

S-amlodipine 5mgDRUG

Sponsors & collaborators

Chong Kun Dang Pharmaceuticallead sponsor

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01983735 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.